ArticleScientific reports2020

Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover.

Juliana de F Germano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.